Aurinia Pharmaceuticals, Inc. (AUPH)
15.45
-0.23
(-1.47%)
USD |
NASDAQ |
Dec 09, 15:37
Aurinia Pharmaceuticals Total Liabilities (Quarterly): 161.76M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.717B |
| Oncolytics Biotech, Inc. | 10.74M |
| Edesa Biotech, Inc. | 0.6727M |
| Lexaria Bioscience Corp. | 1.572M |
| Xenon Pharmaceuticals, Inc. | 48.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 527.53M |
| Shareholders Equity (Quarterly) | 365.77M |
| Debt to Equity Ratio | 0.2138 |
| Current Ratio | 5.756 |
| Net Debt Paydown Yield | 0.11% |